强大的SARS-CoV-2 3C类蛋白酶抑制剂 (+) -eupenoxide-3,6-diketone (IC50:0.048 μM) 是基于 (+) -eupenoxide合成的;通过内性发酵研究从 (+)
Shoji Maehara1, Moeka Kumamoto2, Shogo Nakajima3,4
1Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo, 1 Gakuen-cho, Fukuyama, Hiroshima, 729-0292, Japan. smaehara@fukuyama-u.ac.jp.
Journal of natural medicines
|February 3, 2025
概括
来自药用植物的内菌显示出作为抗病毒化合物的来源的希望. 研究发现了来自Aspergillus sp.的化合物. 具有针对SARS-CoV-2的活性,为传染病治疗提供了新的途径.
科学领域:
- 微生物学 微生物学
- 自然产品化学 自然产品化学
- 病毒学 病毒学
背景情况:
- 由于SARS-CoV-2突变,COVID-19的出现需要新的抗病毒治疗方法.
- 病毒发展出耐药性,突显出迫切需要新的治疗药物.
- 居住在药用植物中的内菌被假设产生抗病毒物质.
研究的目的:
- 研究药用植物内菌作为抗病毒化合物的来源.
- 识别和描述具有针对SARS-CoV-2活性的新型化合物.
- 探索内性共生在发现新的传染病治疗方法中的潜力.
主要方法:
- 隔离和培养来自Catharanthus roseus的内菌.
- 化学分析以确定由Aspergillus sp.产生的二次代谢物.
- 在体外测试以评估对SARS-CoV-2和蛋白酶抑制的抗病毒活性.
主要成果:
- 亚斯伯菌 sp. 的情况. 从Catharanthus roseus中分离出来,产生 (+) - 欧氧化物及其3基衍生物.
- 这些化合物表现出抗SARS-CoV-2活性.
- 一种新型化合物 (+) -eupenoxide-3,6-diketon被合成,并显示出强大的3C类蛋白酶抑制活性 (IC50:0.048μM).
结论:
- 与药用植物相关的内菌是发现抗病毒药物的宝贵资源.
- 这些已识别的化合物,包括新型二基,显示出开发针对SARS-CoV-2和潜在的其他病毒感染的新疗法的巨大潜力.
- 这项研究支持对内性共生进行探索,以发现新型抗病毒药物.
关键词:
卡塔兰 (Catharanthus roseusus) 是一种的植物.(+) -欧氧化-3,6-二甲.3CL 蛋白酶是一种3CL蛋白酶.它们是内植物 (Endophyte).这就是SARS-CoV-2病毒.更多相关视频
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
18.5K
03:29Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
Published on: May 31, 2024
383
相关概念视频
Sharpless Epoxidation
3.8K
The conversion of allylic alcohols into epoxides using the chiral catalyst was discovered by K. Barry Sharpless and is known as Sharpless epoxidation. The use of a chiral catalyst enables the formation of one enantiomer of the product in excess. This chiral catalyst is mainly a chiral complex of titanium tetraisopropoxide and tartrate ester (specific stereoisomer). The stereoisomer used in the chiral catalyst dictates the formation of the enantiomer of the product. In other words, the use of...
3.8K
Preparation of Epoxides
7.4K
Overview
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of...
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of...
7.4K
